These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12118571)

  • 1. Schering-Plough agrees to pay FDA $500 million and bring factories into compliance.
    Kuehn BM
    J Am Vet Med Assoc; 2002 Jul; 221(2):174, 180. PubMed ID: 12118571
    [No Abstract]   [Full Text] [Related]  

  • 2. Corporate compliance programs for FDA-regulated companies: incentives for their development and the impact of the federal sentencing guidelines for organizations.
    Freyer DH
    Food Drug Law J; 1996; 51(2):225-42. PubMed ID: 11820200
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of the pharmaceutical industry in drug development and approval.
    Beleau MH
    Vet Hum Toxicol; 1998; 40 Suppl 2():17-9. PubMed ID: 9823577
    [No Abstract]   [Full Text] [Related]  

  • 5. Indian generics manufacturer Ranbaxy agrees to pay $500m to settle US fraud and drug safety charges.
    Kay M
    BMJ; 2013 May; 346():f3536. PubMed ID: 23723460
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA bans firms from importing and distributing contaminated animal drugs.
    J Am Vet Med Assoc; 1999 May; 214(10):1459. PubMed ID: 10340065
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-18. PubMed ID: 18345557
    [No Abstract]   [Full Text] [Related]  

  • 8. Playing "kick the FDA"--risk-free to players but hazardous to public health.
    Wood AJ
    N Engl J Med; 2008 Apr; 358(17):1774-5. PubMed ID: 18434649
    [No Abstract]   [Full Text] [Related]  

  • 9. Cautious welcome for FDA pharmacogenomics guidance.
    Katsnelson A;
    Nat Biotechnol; 2005 May; 23(5):510. PubMed ID: 15877053
    [No Abstract]   [Full Text] [Related]  

  • 10. New recommendations to modernize drug manufacturing.
    FDA Consum; 2007; 41(1):4. PubMed ID: 17354283
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA set to tighten guidelines on industry dissemination of information on unapproved uses of medical products.
    Lang L
    Gastroenterology; 2008 Apr; 134(4):905. PubMed ID: 18395067
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug safety on trial.
    Nature; 2005 Mar; 434(7033):545. PubMed ID: 15800579
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA to collect fees from drug companies.
    Minn Med; 1992 Nov; 75(11):46. PubMed ID: 1435650
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA urged to comply with 1997 Reform Act.
    Fox JL
    Nat Biotechnol; 1998 Oct; 16(10):901-2. PubMed ID: 9788335
    [No Abstract]   [Full Text] [Related]  

  • 15. New clinical trials policy at FDA.
    Vastag B
    Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
    [No Abstract]   [Full Text] [Related]  

  • 16. Perception and process at the Food and Drug Administration: obligations and trade-offs in rules and guidances.
    Seiguer E; Smith JJ
    Food Drug Law J; 2005; 60(1):17-32. PubMed ID: 15940852
    [No Abstract]   [Full Text] [Related]  

  • 17. Year 2000 (Y2K) computer compliance guide; guidance for FDA personnel. Food and Drug Administration. Notice.
    Fed Regist; 1999 May; 64(93):26424-6. PubMed ID: 10558534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Out in the open.
    Nat Biotechnol; 2005 Feb; 23(2):153. PubMed ID: 15696130
    [No Abstract]   [Full Text] [Related]  

  • 19. Repeal law that puts "FDA on the payroll of the industry," says former NEJM editor.
    Kmietowicz Z
    BMJ; 2007 Mar; 334(7591):447. PubMed ID: 17332569
    [No Abstract]   [Full Text] [Related]  

  • 20. Fifty years of drug amendments revisited: in easy-to-swallow capsule form.
    Kaplan AH
    Food Drug Law J; 1995; 50 Spec():179-96. PubMed ID: 10343042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.